Edgewell Personal Care Share Slip After 1Q Dented by FX, Lower Outlook

Dow Jones
02-10

By Denny Jacob

 

Edgewell Personal Care shares slipped 6.6% in premarket trading after its latest results were affected by a stronger dollar and its outlook hinted at challenges ahead.

Shares were trading around $29.50. The stock is down 21% over the last year.

The maker of razors and feminine-care products swung to a loss of $2.1 million on $478.4 million in sales. This compares to earnings of $4.8 million on $488.9 million in sales a year earlier.

Sales decreased in its wet shave and feminine care lines businesses, while its sun and skin care business grew.

The company said a strengthening dollar impacted its top- and bottom-line in the quarter and it expects further additional headwinds for the year.

For fiscal 2025, Edgewell said it expects earnings per-share to now be between $2.54 to $2.74 compared to its previous guidance in the range of $2.59 a share to $2.79 a share. Adjusted earnings per-share, meanwhile, are now expected to come in towards the lower end of its forecast set between $3.15 to $3.35, which the company said reflects increased anticipated negative foreign currency changes.

The Shelton, Conn., company said its outlook doesn't reflect potential impacts from U.S. or retaliatory tariffs given their rapidly evolving nature.

Truist Securities' Bill Chappell said in a research note following results that Edgewell's progress with productivity initiatives and international growth is being overshadowed by foreign exchange headwinds and declines in North America.

"With pricing and volumes both under pressure in the U.S. and guidance including a much larger hit from FX… we understand why some investors may stay on the sidelines until the top line sees stabilization and there's more neutral currency dynamics," said Chappell.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

February 10, 2025 09:27 ET (14:27 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10